Antiretroviral therapy in HIV‐positive men is associated with increased apolipoprotein CIII in triglyceride‐rich lipoproteins

Objectives Dyslipidaemia has become a common problem in HIV disease, especially in patients on current antiretroviral therapy. However, the pathogenic mechanisms involved are not well understood or documented using conventional lipid measurements. Methods Using a cross‐sectional design, the prevalen...

Full description

Saved in:

Bibliographic Details
Published in:	HIV medicine Vol. 6; no. 5; pp. 326 - 333
Main Authors:	Rimland, D, Guest, JL, Hernández, I, Del Rio, C, Le, NA, Brown, WV
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Science Ltd 01-09-2005
Subjects:	Adult Aged Aged, 80 and over Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Apolipoprotein C-III Apolipoproteins C - blood Cross-Sectional Studies Dyslipidemias - blood Dyslipidemias - chemically induced HIV HIV Infections - blood HIV Infections - drug therapy HIV Protease Inhibitors - adverse effects HIV Protease Inhibitors - therapeutic use Humans lipoproteins Male Middle Aged Reverse Transcriptase Inhibitors - adverse effects Reverse Transcriptase Inhibitors - therapeutic use triglycerides Triglycerides - blood
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!